As a shareholder of a boatload of JAV, I'm tickled that they finally got a deal done, ANY deal. MYRX gets a drug ready for the market and some cash flow, JAV gets a partner with deep enough pockets to get Dyloject out in the market.
Anyone with an opinion about the efficiacy potential for azixa?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.